Effects of treatment with direct hemoperfusion using a new cytokine abserbent to septic shock
Effects of treatment with direct hemoperfusion using a new cytokine abserbent to septic shock
批准号:
18591980
负责人:
TANIGUCHI Takumi
金额:
$2.59万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2006
资助国家:
日本
项目状态:
已结题
起止时间:
2006 至 2007
中文摘要
本研究检查了使用新的吸收剂CTR进行体外治疗的效果,CTR去除了炎症细胞因子,如THE-alpha,IL-I β和IL-6,对大鼠内毒素休克的死亡率和炎症反应的影响。<Methods>1)评价在大鼠中注射内毒素后立即用CTR进行体外治疗的效果。2)评价在大鼠中注射内毒素后2小时用CTR进行体外治疗的效果。3)评价在大鼠中注射内毒素后用CI R进行体外治疗的剂量相关效果。<Results>1)对于内毒素血症、对照柱和CTR处理组,内毒素注射后8小时的死亡率分别为92%、92%和14%。CTR治疗组的低血压和血浆细胞因子浓度升高以及肺中性粒细胞浸润较其他两组不明显。2)内毒素血症组、对照组和CTR治疗后组注射内毒素后8小时的死亡率分别为83%、83%和33%。对照组、四分之一剂量组、半剂量组和全剂量组注射内毒素后8小时的死亡率分别为92%、58%、42%和17%。半剂量和全剂量CTR治疗组中血浆细胞因子浓度的增加小于内毒素血症组。<Conclusion>CTR柱直接血液灌流单采术降低了死亡率,并对内毒素血症期间的炎症反应具有抑制作用。这些结果表明,CTR柱体外血液净化可用于脓毒症和/或内毒素血症患者。
英文摘要
This research examined effects of the extracorporeal treatment with a new absorbent, CTR, which removed inflammatory cytokines such as THE-alpha, IL-I beta and IL-6, on mortality rate and inflammatory responses to endotoxic shock in rats.<Methods>1) To evaluate the effects of the extracorporeal treatment with CTR immediately after endotoxin injection in rats.2) To evaluate the effects of the extracorporeal treatment with CTR 2 hr after endotoxin injection in rats.3) To evaluate the dose-related effects of the extracorporeal treatment with CI R after endotoxin injection in rats.<Results>1) The mortality rates at 8 hrs after endotoxin injection were 92%, 92%, and 14% for the endotoxemic, control column, and CTR treatment groups, respectively. Hypotension and elevated plasma cytokine concentrations and the infiltration of neutrophils of the lungs were less conspicuous in the CTR treatment group than in the other two groups.2) The mortality rates 8hrs after endotoxin injection were 83%, 83%, and 33% for the endotoxemic, control column, and CTR-posttreatment groups, respectively. The increases of interleukin-6 concentrations were less for the CTR-posttreatment group than the other two groups.3) The mortality rates 8hrs after endotoxin injection were 92%, 58%, 42% and 17% for the control column, quarter dose, half dose, and full dose CTR groups, respectively. The increases in plasma cytokine concentrations were smaller in the half dose and full dose CTR treatment groups than in the endotoxemic group.<Conclusion>Direct hemoperfusion apheresis with CTR column reduced mortality and had inhibitory effects on the inflammatory responses during endotoxemia. These findings suggest that extracorporeal blood purification with CTR column may be available to use for the patients with sepsis and/or endotoxemia.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Dose-related effects of direct hemoperfusion using a cytokine adsorbent column for the treatment of experimental endotoxemia
使用细胞因子吸附柱直接血液灌流治疗实验性内毒素血症的剂量相关效应
DOI:
--
发表时间:
2007
期刊:
Intensive Care Med 33.3
影响因子:
--
作者:
[Taniguchi T, Kurita A, Mukawa C, Yamamoto K, Inaba H]
通讯作者:
Inaba H
A novel adsorbent of circulating bacterial toxins and cytokines : The effect of direct hemoperfusion with CTR column for the treatment of experimental endotoxemia.
循环细菌毒素和细胞因子的新型吸附剂:CTR柱直接血液灌流治疗实验性内毒素血症的效果。
DOI:
--
发表时间:
2006
期刊:
Crit Care Med 34・3
影响因子:
--
作者:
[Taniguchi T, Hirai F, Takemoto Y, Tsuda K, Yamamoto K, Inaba H, et al.]
通讯作者:
et al.
Effects of post-treatment with direct hemoperfusion using a CTR column on mortality and inflammatory responses to endotoxin-induced shock in rats.
使用 CTR 柱进行直接血液灌流后处理对大鼠内毒素诱导休克的死亡率和炎症反应的影响。
DOI:
--
发表时间:
2006
期刊:
Blood Purification 24.5-24.6
影响因子:
--
作者:
[Taniguchi T, Takemoto Y, Tsuda K, Inaba H, et al.]
通讯作者:
et al.
Dose-related effects of direct hemoperfusion using a cytokine adsorbent column for the treatment of experimental endotoxemia.
使用细胞因子吸附柱直接血液灌流治疗实验性内毒素血症的剂量相关效应。
DOI:
--
发表时间:
2007
期刊:
Intensive. Care Med 33・3
影响因子:
--
作者:
[Taniguchi T, Kurita A, Mukawa C, Yamamoto K, Inaba H]
通讯作者:
Inaba H
DOI:
10.1007/s00540-007-0533-y
发表时间:
2007-01-01
期刊:
JOURNAL OF ANESTHESIA
影响因子:
2.8
作者:
[Kanakura, Hiroko, Taniguch, Takumi]
通讯作者:
Taniguch, Takumi
共 6 条
Possibility of direct hemoper fusion using a new cytokine absorbing column
-
批准号:20592118
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.0万
-
财政年份:2008
-
负责人:TANIGUCHI Takumi
-
依托单位:
国内基金
海外基金
登录
查看更多内容
KCTD10对2型免疫反应(Th2)的调控研究
-
批准号:2020JJ4441
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:任凯群
-
依托单位:
IL-6受体泛素化调控机制
-
批准号:32070775
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:李姝
-
依托单位:
乙烯合酶ACS家族的AEF蛋白调节拟南芥开花时间的机制研究
-
批准号:31970735
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:江静
-
依托单位:
USP13调控IL-18诱导的NF-κB活化的分子机制研究
-
批准号:31900556
-
项目类别:青年科学基金项目
-
资助金额:26.0万元
-
批准年份:2019
-
负责人:林恒
-
依托单位:
let-7通过SOCS1调控巨噬细胞极化及其在前列腺癌进展中的作用
-
批准号:81560465
-
项目类别:地区科学基金项目
-
资助金额:38.0万元
-
批准年份:2015
-
负责人:王志刚
-
依托单位:
纳米微粒载NF-κB圈套基因对神经发育缺陷大鼠模型的干预研究
-
批准号:30870892
-
项目类别:面上项目
-
资助金额:8.0万元
-
批准年份:2008
-
负责人:吕路线
-
依托单位: